雜志介紹

Pharmacoepidemiology And Drug Safety雜志介紹

《Pharmacoepidemiology And Drug Safety》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱藥物流行病學(xué)和藥物安全，本刊主要出版、報(bào)道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.4，最新CiteScore 指數(shù)為4.8。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records

  Author: Sun, Cuicui; Zhao, Lixia; Yuan, Yujie; Xiang, Yanxiao; Liu, Anchang

• More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching

  Author: Hung, Eric; Hauben, Manfred; Essex, Henry; Zou, Chen; Bright, Steve

• A systematic review and meta-analysis of observational studies of the association between the use of incretin-based therapies and the risk of pancreatic cancer

  Author: Hidayat, Khemayanto; Zhou, Ying-Yi; Du, Hong-Zhen; Qin, Li-Qiang; Shi, Bi-Min; Li, Zeng-Ning

• Prescribed anti-glaucoma medication consumption and road traffic crash

  Author: Lu, Li; Contrand, Benjamin; Schweitzer, Cedric; Gadegbeku, Blandine; Delcourt, Cecile; Lagarde, Emmanuel

英文介紹

Pharmacoepidemiology And Drug Safety雜志英文介紹

The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report.

Particular areas of interest include:

design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology;

comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world;

methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology;

assessments of harm versus benefit in drug therapy;

patterns of drug utilization;

relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines;

evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.